黑料官网

header-logo
GettyImages-609179959-hero
headshot

Razelle Kurzrock, MD, FACP

Center Associate Director, Professor

view physician profile

Locations

  • Froedtert Hospital
  • Clinical Cancer Center - Froedtert Hospital

Specialties

  • Medical Oncology

Languages

  • English

Clinical Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine
  • FACP - Fellow of the American College of Physicians

Leadership Positions

  • Associate Director of Clinical Research, Cancer Center
  • Associate Director of Clinical Research, GSPMC

Publications

  • (Subbiah V, Kurzrock R.) J Clin Oncol. 2025 Nov 10;43(32):3446-3450 PMID: 40961399 SCOPUS ID: 2-s2.0-105021037485 09/17/2025

  • (Uehara Y, Nishizaki D, Fujiwara Y, Miyashita H, Lee S, Pabla S, DePietro P, Ko H, Jensen TJ, Sicklick JK, Kato S, Kurzrock R.) Cancer Immunol Immunother. 2025 Nov 03;74(12):359 PMID: 41182434 PMCID: PMC12583269 SCOPUS ID: 2-s2.0-105020738477 11/03/2025

  • (Nikanjam M, Kurzrock R.) Semin Cancer Biol. 2025 Oct 30;117:57-68 PMID: 41175949 SCOPUS ID: 2-s2.0-105020792288 11/02/2025

  • (Patel SP, Othus M, Chae YK, Azenkot T, Wagner MJ, Threlkel S, Farley JH, Magner CM, Chen HX, Sharon E, Ryan CW, Blanke C, Kurzrock R.) J Immunother Cancer. 2025 Oct 20;13(10) PMID: 41120126 PMCID: PMC12542749 SCOPUS ID: 2-s2.0-105019730697 10/22/2025

  • (Subbiah V, Kurzrock R.) Nat Med. 2025 Oct;31(10):3290-3291 PMID: 40931035 SCOPUS ID: 2-s2.0-105016134568 09/11/2025

  • (Gianchandani A, Desai D, Sambath J, Patil D, Kumar P, Singh S, Madre C, Deshpande R, Parab A, Shah N, Shah D, Kataria P, Atluri S, Mehta M, Shreenivas A, Datar R, Kurzrock R, Limaye S.) J Immunother Precis Oncol. 2025 Aug;8(3):206-211 PMID: 40927311 PMCID: PMC12416483 09/10/2025

  • (Hsieh ML, Nishizaki D, Adashek JJ, Kato S, Kurzrock R.) Biomarker Research. December 2025;13(1) SCOPUS ID: 2-s2.0-85218427562 12/01/2025

  • (Stewart DJ, Zhang B, Kurzrock R.) Lung Cancer. December 2025;210 SCOPUS ID: 2-s2.0-105021860187 12/01/2025

  • (Grewal US, Clarke CN, Kurzrock R.) Med. 14 November 2025;6(11) SCOPUS ID: 2-s2.0-105021318570 11/14/2025

  • (Dizon DS, Pal SK, Symington BE, Kurzrock R, Kamal AH, Annunziata CM, Sivendran S, Jemal A, Dahut WL.) CA Cancer J Clin. 2025;75(6):469-472 PMID: 41182178 PMCID: PMC12593277 SCOPUS ID: 2-s2.0-105020749778 11/03/2025

  • (Larkin B, Nishizaki D, Miyashita H, Lee S, Nikanjam M, Eskander RN, Jensen TJ, Pabla S, Conroy JM, DePietro P, Sicklick JK, Kurzrock R, Kato S.) Immunotargets Ther. 2025;14:967-977 PMID: 40937367 PMCID: PMC12420428 09/12/2025

  • (Landau O, Magidi S, Bresson C, Wunder F, Kurzrock R, El-Deiry WS, Thangathurai K, Rubin E.) Front Pharmacol. 2025;16:1588191 PMID: 40880638 PMCID: PMC12380929 SCOPUS ID: 2-s2.0-105014910954 08/31/2025

Publications of from the

© 2025 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.